Drugs / SAR422459
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01367444 | Jun 2011 → Aug 2019 | Stargardt disease | Sanofi | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SAR422459 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01367444 ↗ |
| Route | Other | “Route of administration: subretinal injection” NCT01367444 ↗ |